{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:06:31Z","timestamp":1780607191054,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.biopha.2018.03.075","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T11:00:10Z","timestamp":1523358010000},"page":"1195-1202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82"],"prefix":"10.1016","volume":"102","author":[{"given":"Jianwen","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2018.03.075_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8120110","article-title":"Biology, therapy and implications of tumor exosomes in the progression of melanoma","volume":"8","author":"Isola","year":"2016","journal-title":"Cancers"},{"issue":"65","key":"10.1016\/j.biopha.2018.03.075_bib0010","article-title":"Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992\u20132006","volume":"5","author":"Jemal","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"114","key":"10.1016\/j.biopha.2018.03.075_bib0015","first-page":"196","article-title":"Incidence, survival, and mortality of malignant cutaneous melanoma in Wisconsin, 1995-2011","volume":"5","author":"Peterson","year":"2015","journal-title":"WMJ"},{"issue":"56","key":"10.1016\/j.biopha.2018.03.075_bib0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/0284186X.2016.1243804","article-title":"Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study","volume":"1","author":"Padrik","year":"2017","journal-title":"Acta Oncol."},{"issue":"27","key":"10.1016\/j.biopha.2018.03.075_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/CMR.0000000000000332","article-title":"Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors","volume":"2","author":"Tas","year":"2017","journal-title":"Melanoma. Res."},{"issue":"93","key":"10.1016\/j.biopha.2018.03.075_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejcb.2014.02.001","article-title":"The role of microRNAs in melanoma","volume":"1\u20132","author":"Luo","year":"2014","journal-title":"Eur. J. Cell Biol"},{"issue":"170","key":"10.1016\/j.biopha.2018.03.075_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjd.12493","article-title":"Molecular markers in melanoma","volume":"1","author":"Kashani-Sabet","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"38","key":"10.1016\/j.biopha.2018.03.075_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2500\/aap.2017.38.4013","article-title":"Involvement of microRNAs in skin disorders: a literature review","volume":"1","author":"Mannucci","year":"2017","journal-title":"Allergy Asthma Proc."},{"issue":"20","key":"10.1016\/j.biopha.2018.03.075_bib0045","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.2174\/1381612820666140128210105","article-title":"MicroRNAs in cancer: lessons from melanoma","volume":"33","author":"Greenberg","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.biopha.2018.03.075_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12265-010-9186-6","article-title":"Disease genes and gene regulation by microRNAs","volume":"3","author":"Roberts","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"148","key":"10.1016\/j.biopha.2018.03.075_bib0055","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"6","author":"Mendell","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.03.075_bib0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopha.2018.01.086","article-title":"miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3beta","volume":"99","author":"Song","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.03.075_bib0065","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9032502","article-title":"MiR-219-5p Inhibits the Growth and Metastasis of Malignant Melanoma by Targeting BCL-2","author":"Long","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"23","key":"10.1016\/j.biopha.2018.03.075_bib0070","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.2174\/1389557516666160831164544","article-title":"miRNAs in melanoma: tumor suppressors and oncogenes with prognostic potential","volume":"28","author":"Wozniak","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2018.03.075_bib0075","doi-asserted-by":"crossref","first-page":"10932","DOI":"10.1038\/s41598-017-10977-9","article-title":"MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin","volume":"1","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.03.075_bib0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13578-016-0112-8","article-title":"Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p","volume":"6","author":"Xing","year":"2016","journal-title":"Cell. Biosci."},{"issue":"Apr. (3)","key":"10.1016\/j.biopha.2018.03.075_bib0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10571-017-0525-x","article-title":"MiR-338-5p promotes glioma cell invasion by regulating TSHZ3 and MMP2","volume":"38","author":"Li","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2018.03.075_bib0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.biopha.2017.01.137","article-title":"MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1","volume":"89","author":"Lei","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.03.075_bib0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1471-2407-13-280","article-title":"Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer","volume":"13","author":"Yong","year":"2013","journal-title":"BMC Cancer"},{"issue":"34","key":"10.1016\/j.biopha.2018.03.075_bib0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10555-015-9585-x","article-title":"Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity","volume":"4","author":"Feng","year":"2015","journal-title":"Cancer Metastasis Rev."},{"issue":"35","key":"10.1016\/j.biopha.2018.03.075_bib0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/carcin\/bgt346","article-title":"Prognostic significance of KAI1\/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4","volume":"1","author":"Tang","year":"2014","journal-title":"Carcinogenesis"},{"issue":"28","key":"10.1016\/j.biopha.2018.03.075_bib0110","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/pcmr.12399","article-title":"The role of the metastasis suppressor gene KAI1 in melanoma angiogenesis","volume":"6","author":"Tang","year":"2015","journal-title":"Pigm. Cell Melanoma Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221735028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221735028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:00:07Z","timestamp":1731427207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221735028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":22,"alternative-id":["S075333221735028X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.075","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}